Natco Pharma Ltd. logo

Natco Pharma Ltd. (NATCOPHARM)

Market Open
16 Jun, 10:00
XNSE XNSE
855. 60
+8.6
+1.0153%
175.34B Market Cap
13.93 P/E Ratio
5% Div Yield
104,516 Volume
0 Eps
847
Previous Close
Add Transaction
Day Range
848.8 857.5
Year Range
789 1,226.8
Want to track NATCOPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
29 May 2026
5.4
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Feb 2026
8.67
8.46
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
14 Nov 2025
24.56
28.94
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
11 Aug 2025
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Feb 2025
13.36
7.43
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Nov 2024
31.5
37.81
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
27 Sep 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
7 Aug 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
27 May 2024
16.01
21.56
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
7 Feb 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
8 Nov 2023
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
11 Nov 2016
1.87
3.8
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
10 Feb 2014
3.44
10.12
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
14 Nov 2013
9.3
9.34

NATCOPHARM Earnings Reports FAQ

What is the earnings per share (EPS) for NATCOPHARM?

The current EPS is 0.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately -0.82%, reflecting the NATCOPHARM's performance and XNSE market conditions.

When is the next earnings release date?

Natco Pharma Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Natco Pharma Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for NATCOPHARM at this time, as Natco Pharma Ltd has no recent EPS data to calculate it.